The evidence
Publications
- 01Lymphatic Delivery of Etanercept Achieves Significant Improvements in Rheumatoid Arthritis Disease Measures at 50% of the Standard Dose for Patients with an Inadequate Response to Subcutaneous InjectionsRead paper
- 02American College of Rheumatology PosterRead paper
- 03Delivering an mRNA vaccine using a lymphatic drug delivery device improves humoral and cellular immunity against SARS-CoV-2Read paper
- 04785 A phase I study of intralymphatic (IL) administration of ipilimumab (IPI) with intravenous nivolumab (NIVO) using the Sofusa® DoseConnect™ device in patients with advanced melanomaRead paper
- 05Anti-tumoral effects of novel lymphatic delivery of anti-CTLA4 in a metastatic murine breast cancer model. American Association for Cancer Research (AACR)Read paper
- 06Nanotopography Facilitates in Vivo Transdermal Delivery of High Molecular Weight Therapeutics through an Integrin-Dependent MechanismRead paper
- 07Nanostructure-Mediated Transport of Biologics across Epithelial Tissue: Enhancing Permeability via NanotopographyRead paper
- 08Nanotopography-based lymphatic delivery for improved anti-tumor responses to checkpoint blockade immunotherapyRead paper
Back home